Jubilant Organosys, the University of Alabama at Birmingham (UAB), and Southern Research Institute formed a joint venture leveraging their collective technologies in the areas of oncology, metabolic disease and infectious diseases. The goal of the partnership is to select and develop new drugs from promising biological targets discovered by researchers at UAB, Southern Research and Jubilant; use early research data to secure federal funding to create new research jobs; develop drugs through prec...